Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Mark Doherty

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Plos One|November 22, 2013
Combination of cytokine responses indicative of latent TB and active TB in Malawian adultsYun-Gyoung Hur, Patricia Gorak-Stolinska, Anne Ben-Smith, et al.
Vaccine|May 21, 2022
Capturing the value of vaccination within health technology assessment and health economics: Country analysis and priority value conceptsMaarten Postma, Eliana Biundo, Annie Chicoye, et al.
Plos Medicine|July 4, 2008
Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendationsWillem A Hanekom, Hazel M Dockrell, Tom H M Ottenhoff, et al.
The Journal of Infectious Diseases|November 20, 2004
Comparative analysis of different vaccine constructs expressing defined antigens from Mycobacterium tuberculosisT Mark Doherty, Anja W Olsen, Joachim Weischenfeldt, et al.
Clinical and Vaccine Immunology : CVI|May 14, 2010
Variation in gamma interferon responses to different infecting strains of Mycobacterium tuberculosis in acid-fast bacillus smear-positive patients and household contacts in Antananarivo, MadagascarNiaina Rakotosamimanana, Vaomalala Raharimanga, Soa Fy Andriamandimby, et al.
European Journal of Immunology|October 31, 2009
Expression of apoptosis-related genes in an Ethiopian cohort study correlates with tuberculosis clinical statusMarkos Abebe, T Mark Doherty, Liya Wassie, et al.
American Journal of Respiratory and Critical Care Medicine|May 29, 2010
Heparin-binding, hemagglutinin-specific IFN-gamma synthesis at the site of infection during active tuberculosis in humansSammy Place, Virginie Verscheure, Nour de San, et al.
Scientific Reports|December 13, 2016
BLR1 and FCGR1A transcripts in peripheral blood associate with the extent of intrathoracic tuberculosis in children and predict treatment outcomeSynne Jenum, Rasmus Bakken, S Dhanasekaran, et al.
Vaccine|March 16, 2010
Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteersJaap T van Dissel, Sandra M Arend, Corine Prins, et al.
Trials|January 12, 2018
A phase I, open-label trial on the safety and immunogenicity of the adjuvanted tuberculosis subunit vaccine H1/IC31® in people living in a TB-endemic areaJemal Hussein, Martha Zewdie, Lawrence Yamuah, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Plos One|November 22, 2013
Combination of cytokine responses indicative of latent TB and active TB in Malawian adultsYun-Gyoung Hur, Patricia Gorak-Stolinska, Anne Ben-Smith, et al.
Vaccine|May 21, 2022
Capturing the value of vaccination within health technology assessment and health economics: Country analysis and priority value conceptsMaarten Postma, Eliana Biundo, Annie Chicoye, et al.
Plos Medicine|July 4, 2008
Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendationsWillem A Hanekom, Hazel M Dockrell, Tom H M Ottenhoff, et al.
The Journal of Infectious Diseases|November 20, 2004
Comparative analysis of different vaccine constructs expressing defined antigens from Mycobacterium tuberculosisT Mark Doherty, Anja W Olsen, Joachim Weischenfeldt, et al.
Clinical and Vaccine Immunology : CVI|May 14, 2010
Variation in gamma interferon responses to different infecting strains of Mycobacterium tuberculosis in acid-fast bacillus smear-positive patients and household contacts in Antananarivo, MadagascarNiaina Rakotosamimanana, Vaomalala Raharimanga, Soa Fy Andriamandimby, et al.
European Journal of Immunology|October 31, 2009
Expression of apoptosis-related genes in an Ethiopian cohort study correlates with tuberculosis clinical statusMarkos Abebe, T Mark Doherty, Liya Wassie, et al.
American Journal of Respiratory and Critical Care Medicine|May 29, 2010
Heparin-binding, hemagglutinin-specific IFN-gamma synthesis at the site of infection during active tuberculosis in humansSammy Place, Virginie Verscheure, Nour de San, et al.
Scientific Reports|December 13, 2016
BLR1 and FCGR1A transcripts in peripheral blood associate with the extent of intrathoracic tuberculosis in children and predict treatment outcomeSynne Jenum, Rasmus Bakken, S Dhanasekaran, et al.
Vaccine|March 16, 2010
Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteersJaap T van Dissel, Sandra M Arend, Corine Prins, et al.
Trials|January 12, 2018
A phase I, open-label trial on the safety and immunogenicity of the adjuvanted tuberculosis subunit vaccine H1/IC31® in people living in a TB-endemic areaJemal Hussein, Martha Zewdie, Lawrence Yamuah, et al.
Pageof 10